Stryker ROE 2006-2019 | SYK
Current and historical return on equity (ROE) values for Stryker (SYK) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Stryker ROE for the three months ending March 31, 2019 was 26.72%.
| Stryker ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2019-03-31 | $3.52B | $11.69B | 32.96% |
| 2018-12-31 | $3.55B | $11.73B | 35.29% |
| 2018-09-30 | $1.24B | $9.86B | 12.83% |
| 2018-06-30 | $1.08B | $9.46B | 11.05% |
| 2018-03-31 | $1.02B | $9.22B | 10.28% |
| 2017-12-31 | $1.02B | $9.98B | 10.16% |
| 2017-09-30 | $1.78B | $10.43B | 17.92% |
| 2017-06-30 | $1.70B | $10.04B | 17.61% |
| 2017-03-31 | $1.69B | $9.70B | 17.93% |
| 2016-12-31 | $1.65B | $9.55B | 17.91% |
| 2016-09-30 | $1.66B | $9.33B | 18.56% |
| 2016-06-30 | $1.61B | $9.10B | 18.39% |
| 2016-03-31 | $1.62B | $8.81B | 18.85% |
| 2015-12-31 | $1.44B | $8.51B | 17.02% |
| 2015-09-30 | $1.18B | $8.48B | 13.89% |
| 2015-06-30 | $0.93B | $8.51B | 10.96% |
| 2015-03-31 | $0.67B | $8.32B | 7.75% |
| 2014-12-31 | $0.52B | $8.60B | 5.84% |
| 2014-09-30 | $0.64B | $8.62B | 7.17% |
| 2014-06-30 | $0.69B | $9.00B | 7.67% |
| 2014-03-31 | $0.77B | $9.06B | 8.71% |
| 2013-12-31 | $1.01B | $9.05B | 11.55% |
| 2013-09-30 | $0.89B | $8.74B | 10.35% |
| 2013-06-30 | $1.14B | $8.60B | 13.41% |
| 2013-03-31 | $1.25B | $8.46B | 15.01% |
| 2012-12-31 | $1.30B | $8.60B | 15.77% |
| 2012-09-30 | $1.43B | $8.36B | 17.85% |
| 2012-06-30 | $1.40B | $7.95B | 17.98% |
| 2012-03-31 | $1.39B | $8.02B | 17.89% |
| 2011-12-31 | $1.35B | $7.68B | 17.66% |
| 2011-09-30 | $1.24B | $7.56B | 16.54% |
| 2011-06-30 | $1.25B | $7.78B | 16.82% |
| 2011-03-31 | $1.26B | $7.45B | 17.55% |
| 2010-12-31 | $1.27B | $7.17B | 18.25% |
| 2010-09-30 | $1.28B | $7.31B | 18.80% |
| 2010-06-30 | $1.18B | $6.75B | 17.78% |
| 2010-03-31 | $1.15B | $6.67B | 17.82% |
| 2009-12-31 | $1.11B | $6.60B | 17.91% |
| 2009-09-30 | $1.08B | $6.44B | 18.34% |
| 2009-06-30 | $1.12B | $6.06B | 19.69% |
| 2009-03-31 | $1.14B | $5.63B | 19.81% |
| 2008-12-31 | $1.15B | $5.41B | 19.72% |
| 2008-09-30 | $1.15B | $5.75B | 19.71% |
| 2008-06-30 | $1.10B | $6.22B | 19.43% |
| 2008-03-31 | $1.07B | $5.93B | 20.02% |
| 2007-12-31 | $1.02B | $5.38B | 20.54% |
| 2007-09-30 | $0.97B | $5.16B | 20.81% |
| 2007-06-30 | $0.93B | $4.80B | 21.27% |
| 2007-03-31 | $0.87B | $4.49B | 21.27% |
| 2006-12-31 | $0.78B | $4.19B | 20.16% |
| 2006-09-30 | $0.73B | $3.99B | 20.02% |
| 2006-06-30 | $0.66B | $3.77B | 19.34% |
| 2006-03-31 | $0.63B | $3.49B | 19.39% |
| 2005-12-31 | $0.64B | $3.30B | 20.94% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $78.520B | $13.601B |
| Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $154.825B | 29.16 |
| Medtronic (MDT) | Ireland | $135.913B | 19.41 |
| Boston Scientific (BSX) | United States | $59.297B | 28.43 |
| Baxter (BAX) | United States | $42.385B | 26.71 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $29.267B | 0.00 |
| Coloplast (CLPBY) | Denmark | $25.937B | 41.41 |
| Zimmer Biomet Holdings (ZBH) | United States | $25.411B | 16.33 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.385B | 0.00 |
| Terumo (TRUMY) | Japan | $21.889B | 25.17 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $19.108B | 0.00 |
| ResMed (RMD) | United States | $17.890B | 34.18 |
| Canopy Growth (CGC) | Canada | $12.379B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $12.175B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.239B | 48.98 |
| Insulet (PODD) | United States | $7.299B | 531.83 |
| William Demant Holdings (WILYY) | Denmark | $7.263B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $7.083B | 21.47 |
| Aurora Cannabis (ACB) | Canada | $7.048B | 69.50 |
| Perrigo (PRGO) | Ireland | $6.991B | 11.82 |
| GN STORE NORD (GNNDY) | Denmark | $6.409B | 32.73 |
| Haemonetics (HAE) | United States | $6.299B | 51.41 |
| ICU Medical (ICUI) | United States | $5.103B | 30.45 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $5.007B | 0.00 |
| Neogen (NEOG) | United States | $3.388B | 55.09 |
| NuVasive (NUVA) | United States | $3.018B | 24.64 |
| Agios Pharmaceuticals (AGIO) | United States | $2.894B | 0.00 |
| Hutchison China MediTech (HCM) | China | $2.829B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.507B | 53.42 |
| Quidel (QDEL) | United States | $2.307B | 23.94 |
| Aphria (APHA) | $1.619B | 0.00 | |
| Cardiovascular Systems (CSII) | United States | $1.549B | 889.60 |
| Phibro Animal Health (PAHC) | United States | $1.229B | 18.42 |
| AtriCure (ATRC) | United States | $1.216B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.171B | 24.86 |
| NanoString Technologies (NSTG) | United States | $1.107B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $1.086B | 28.83 |
| PetIQ (PETQ) | United States | $1.002B | 24.33 |
| Quanterix (QTRX) | United States | $0.820B | 0.00 |
| Cerus (CERS) | United States | $0.773B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.761B | 21.35 |
| Omeros (OMER) | United States | $0.760B | 0.00 |
| MacroGenics (MGNX) | United States | $0.739B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.701B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.608B | 29.43 |
| Surmodics (SRDX) | United States | $0.538B | 78.24 |
| OraSure Technologies (OSUR) | United States | $0.525B | 24.17 |
| Meridian Bioscience (VIVO) | United States | $0.492B | 15.03 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.465B | 0.00 |
| Vapotherm (VAPO) | United States | $0.327B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.324B | 22.45 |
| BioLife Solutions (BLFS) | United States | $0.319B | 99.82 |
| Cytosorbents (CTSO) | United States | $0.246B | 0.00 |
| Zynex (ZYXI) | United States | $0.239B | 24.60 |
| Bovie Medical (APYX) | United States | $0.214B | 0.00 |
| Chimerix (CMRX) | United States | $0.186B | 0.00 |
| United Health Products (UEEC) | United States | $0.171B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.167B | 0.00 |
| Owens & Minor (OMI) | United States | $0.166B | 3.52 |
| Fonar (FONR) | United States | $0.139B | 7.32 |
| Female Health (VERU) | United States | $0.138B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.100B | 0.00 |
| United-Guardian (UG) | United States | $0.091B | 19.97 |
| InfuSystems Holdings (INFU) | United States | $0.088B | 0.00 |
| Surface Oncology (SURF) | United States | $0.079B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.069B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.056B | 19.25 |
| MRI INTERVENTNS (MRIC) | United States | $0.052B | 0.00 |
